与 «HYPERCHOLESTEROLEMIA»相关的英语书籍
在以下的参考文献中发现
hypercholesterolemia的用法。与
hypercholesterolemia相关的书籍以及同一来源的简短摘要提供其在 英语文献中的使用情境。
1
Familial
Hypercholesterolemia: New Insights for the ...
The editors have built Familial Hypercholesterolemia: New Insights for the Healthcare Professional: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Additional Research in this book to ...
2
Textbook of Cardiovascular Medicine
It is characterized by elevated LDL-C levels (usually 200 to 400 mg/dL) with
normal triglycerides and a family history of hypercholesterolemia or premature
cardiovascular disease. The finding of tendon xanthomas is virtually diagnostic of
FH ...
Eric J. Topol, Robert M. Califf,
2007
3
Hypercholesterolemia: New Insights for the Healthcare ...
(2010 JUL 6) National Cardiovascular Center, Osaka: A novel Thr56Met mutation
of the autosomal recessive hypercholesterolemia gene associated with
hypercholesterolemia A new study, 'A novel Thr56Met mutation of the autosomal
...
4
Holistic Therapies for Remedying
Hypercholesterolemia-vs- ...
Ava Newman, R.Ph.,Ph.D., Ph.D., Ava, RPh Newman. Implications There results
and conclusions drawn from this study could have a powerful impact on the
remedying of hypercholesterolemia. This information in this study benefits
individuals ...
Ava Newman, R.Ph.,Ph.D., Ph.D., Ava, RPh Newman,
2010
5
Immune-mediated Oxidative Stress and Endothelium-dependent ...
Therefore, it has become increasingly apparent that hypercholesterolemia-
induced vascular disease is a complex process involving profound pathologic
changes in both large arteries and the microvessels, with the vasculature
assuming a ...
Ryan Michael Wolfort,
2008
6
Hypercholesterolemia: New Insights for the Healthcare ...
The prevalences of obesity, hypertension, hypercholesterolemia, diabetes, and
smoking were calculated in 5-year age groups for each year. Overall prevalence
estimates were adjusted for age using the indirect method. For male workers, the
...
7
Principles of Pharmacology: The Pathophysiologic Basis of ...
From a clinical perspective, the dyslipidemias can be divided into
hypercholesterolemia, hypertriglyceridemia, mixed hyperlipidemia, and disorders
of HDL metabolism. Numerous causes of hyperlipidemia are appreciated. These
include ...
David E. Golan, Armen H. Tashjian, Ehrin J. Armstrong,
2011
8
The Effects of Peripheral
Hypercholesterolemia on Brain ...
Naomi Yamada. 10. Barger SW and Mattson MP. The secreted form of the
Alzheimer's beta-amyloid precursor protein stimulates a membrane-associated
guanylate cyclase. Biochem J. 1995;311:45-7. 11. Mattson MP, Barger SW,
Cheng B, ...
9
Cardiovascular Therapeutics: A Companion to Braunwald's ...
Portacaval shunt in patients with familial hypercholesterolemia. Ann Surg 1983;
198:273-283. Forman MB, Baker SG, Mieny CJ, et al. Treatment of homozygous
familial hypercholesterolaemia with portacaval shunt. Atherosclerosis 1982 ...
10
Modern Nutrition in Health and Disease
Another pattern of LDL metabolism responsible for moderate
hypercholesterolemia is a reduced fractional clearance of LDL. This abnormality
presumably reflects a decreased availability of LDL receptors (14, 52). Some of
the dictator acquired ...
Maurice Edward Shils, Moshe Shike,
2006
包含词语«HYPERCHOLESTEROLEMIA»的新条目
找出国内和国际出版社所讨论的内容，以及词语
hypercholesterolemia在以下新条目的上下文中是如何使用的。
Esperion Therapeutics (NASDAQ:ESPR), Nielsen NV (NYSE:NLSN)
Its products comprise ETC-1002, an oral molecule therapy that is in Phase 2b clinical trials to treat patients with hypercholesterolemia, ... «wsnewspublishers, 七月 15»
Esperion Therapeutics Receives Average Recommendation of “Buy …
ETC-1002 is being developed for patients with hypercholesterolemia. One completed Phase IIb clinical study and a second that is nearing completion build ... «Dakota Financial News, 七月 15»
Sanofi restructuring business to drive growth | BioPharma Dive
And although Sanofi did not beat Amgen to market with its PSCK-9 inhibitor for hypercholesterolemia, Praluent (alirocumab), in Europe, there is ... «BioPharma Dive, 七月 15»
(NASDAQ:PMCS), Organovo Holdings (NYSEMKT:ONVO)
Its principal products comprise Crestor for the treatment of dyslipidaemia and hypercholesterolemia; Seloken/Toprol-XL to control hypertension, ... «wsnewspublishers, 七月 15»
Prevalence of FH is Common in ACS Patients, Remains Undertreated
LAUSANNE, SWITZERLAND — The prevalence of phenotype-diagnosed familial hypercholesterolemia (FH) is common among patients ... «Medscape, 七月 15»
CymaBay Therapeutics Announces Pricing of $20 Million Public …
CymaBay has initiated a pilot study of MBX-8025 in patients with homozygous familial hypercholesterolemia. Forward-Looking Statement ... «MarketWatch, 七月 15»
Mechanism that adjusts the function of the nervous system to the …
Production of this molecule is increased, for example, in situations of obesity, dyslipidaemias, lipodystrophies, hypercholesterolemia, insulin ... «Medical Xpress, 七月 15»
Cerenis Therapeutics Announces the Results of the LOCATION Study
... patients with homozygous familial hypercholesterolemia, and in post-ACS patients. We will be submitting the full results from the LOCATION ... «Business Wire, 七月 15»
Analytic Report on Valeant Pharmaceuticals International (NYSE:VRX)
... Sublinox to treat insomnia; and Lodalis to treat hypercholesterolemia. Further, the company provides Cold-FX to strengthen immune system; ... «Markets Wired, 七月 15»
Insider Selling: Regeneron Pharmaceuticals Director Joseph L …
... and a rare inflammatory condition and has product candidates under development in other areas, including hypercholesterolemia, oncology, ... «sleekmoney, 七月 15»